David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$410M |
| 2 |
Chevron
CVX
|
+$400M |
| 3 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$381M |
| 4 |
Williams Companies
WMB
|
+$300M |
| 5 |
SLB Ltd
SLB
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$358M |
| 3 |
Biogen
BIIB
|
+$306M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$298M |
| 5 |
Bausch Health
BHC
|
+$298M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 11.89% |
| 2 | Technology | 10.04% |
| 3 | Healthcare | 9.38% |
| 4 | Consumer Discretionary | 8.99% |
| 5 | Industrials | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
Southwest Gas
SWX
$6.49B
| $292K | ﹤0.01% |
5,486
-638
| -10% | -$35K |
|
|
NE
3402
DELISTED
Noble Corporation
NE
| $290K | ﹤0.01% |
18,840
-35,967
| -66% | -$594K |
|
|
NWLIA
3403
DELISTED
NATL WESTN LIFE INS CO CL A
NWLIA
| $290K | ﹤0.01% |
+1,209
| New | +$290K |
|
3404
BGC Group
BGC
$5.68B
| $289K | ﹤0.01% |
+51,324
| New | +$311K |
|
3405
Jones Lang LaSalle
JLL
$17.8B
| $289K | ﹤0.01% |
+1,692
| New | +$286K |
|
|
ARO
3406
DELISTED
Aeropostale Inc
ARO
| $289K | ﹤0.01% |
178,193
-562,982
| -76% | -$1.48M |
|
3407
Manulife Financial
MFC
$71B
| $288K | ﹤0.01% |
15,500
-195,440
| -93% | -$3.63M |
|
3408
PetMed Express
PETS
$37.9M
| $288K | ﹤0.01% |
16,665
-19,084
| -53% | -$320K |
|
|
AMPE
3409
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $288K | ﹤0.01% |
405
+82
| +25% | +$87.4K |
|
|
VSI
3410
DELISTED
Vitamin Shoppe Inc.
VSI
| $286K | ﹤0.01% |
+7,666
| New | +$307K |
|
3411
PUT
Huntsman Corp
HUN
$1.68B
| $285K | ﹤0.01% |
12,900
| – | – |
|
3412
PUT
Qualys
QLYS
$6.17B
| $282K | ﹤0.01% |
+7,000
| New | +$314K |
|
|
CAVM
3413
DELISTED
Cavium, Inc.
CAVM
| $282K | ﹤0.01% |
+4,100
| New | +$287K |
|
3414
Chemed
CHE
$7.08B
| $280K | ﹤0.01% |
2,133
-5,189
| -71% | -$642K |
|
3415
Puma Biotechnology
PBYI
$471M
| $280K | ﹤0.01% |
2,400
-86,148
| -97% | -$15.6M |
|
3416
Telkom Indonesia
TLK
$14.8B
| $280K | ﹤0.01% |
12,926
-78,798
| -86% | -$1.7M |
|
|
ELNK
3417
DELISTED
EarthLink Holdings Corp.
ELNK
| $280K | ﹤0.01% |
37,401
-56,790
| -60% | -$344K |
|
|
ADAP
3418
DELISTED
Adaptimmune Therapeutics
ADAP
| $279K | ﹤0.01% |
+15,232
| New | +$261K |
|
|
LITB
3419
LightInTheBox
LITB
$57.6M
| $279K | ﹤0.01% |
+10,109
| New | +$301K |
|
3420
Companhia Siderúrgica Nacional
SID
$1.37B
| $279K | ﹤0.01% |
168,763
+115,399
| +216% | +$247K |
|
|
USG
3421
CALL
DELISTED
Usg
USG
| $278K | ﹤0.01% |
10,000
| – | – |
|
3422
Huntington Bancshares
HBAN
$34.4B
| $277K | ﹤0.01% |
24,463
-3,612
| -13% | -$40.4K |
|
|
AVHI
3423
DELISTED
A V Homes, Inc.
AVHI
| $277K | ﹤0.01% |
19,255
+7,898
| +70% | +$123K |
|
3424
CALL
Harley-Davidson
HOG
$2.94B
| $276K | ﹤0.01% |
4,900
| – | – |
|
3425
Builders FirstSource
BLDR
$7.56B
| $275K | ﹤0.01% |
21,438
-56,697
| -73% | -$692K |
|
Similar funds
David Shaw's Q2 2015 Portfolio in Review
As of Q2 2015, David Shaw held 4,083 positions worth $67.1B, up 2.8% from $65.3B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw's Q2 2015 filing shows 504 new, 1,541 increased, 1,229 reduced and 364 closed positions. Its largest new stake was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $479M.
By sector, the portfolio is most concentrated in Energy at 12% of assets, up from 10% a quarter earlier, followed by Technology and Healthcare.
- David Shaw's largest Q2 2015 buy was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M.
- David Shaw added most to Gilead Sciences in Q2 2015, an estimated $410M increase.
- David Shaw's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $479M.
- David Shaw fully exited TRW AUTOMOTIVE HOLDINGS CORP in Q2 2015, selling an estimated $164M.
- David Shaw's ten largest holdings make up 11% of its $67.1B portfolio in Q2 2015.
- David Shaw opened 504 new positions and closed 364 in Q2 2015.
- David Shaw's portfolio value rose 2.8% quarter-over-quarter to $67.1B.
Based on D.E. Shaw & Co's 13F filing for Q2 2015, filed 14 Aug 2015.